BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19825429)

  • 1. Capsaicin inhibits IFN-gamma-induced MHC class II expression by suppressing transcription of class II transactivator gene in murine peritoneal macrophages.
    Mahmoud ME; Nikami H; Shiina T; Takewaki T; Shimizu Y
    Int Immunopharmacol; 2010 Jan; 10(1):86-90. PubMed ID: 19825429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W; Tang LP; Dong Y; Benveniste EN
    J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guérin involves class II transactivator and depends on the Nramp1 gene.
    Wojciechowski W; DeSanctis J; Skamene E; Radzioch D
    J Immunol; 1999 Sep; 163(5):2688-96. PubMed ID: 10453010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
    Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes.
    Lee YJ; Benveniste EN
    J Immunol; 1996 Aug; 157(4):1559-68. PubMed ID: 8759739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression.
    Lee YJ; Han Y; Lu HT; Nguyen V; Qin H; Howe PH; Hocevar BA; Boss JM; Ransohoff RM; Benveniste EN
    J Immunol; 1997 Mar; 158(5):2065-75. PubMed ID: 9036950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE; Cooper S; Hangoc G; Chang CH
    Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA.
    Han Y; Zhou ZH; Ransohoff RM
    J Immunol; 1999 Aug; 163(3):1435-40. PubMed ID: 10415044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha.
    Lüder CG; Walter W; Beuerle B; Maeurer MJ; Gross U
    Eur J Immunol; 2001 May; 31(5):1475-84. PubMed ID: 11465104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo.
    Hobart M; Ramassar V; Goes N; Urmson J; Halloran PF
    J Immunol; 1997 May; 158(9):4260-9. PubMed ID: 9126988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta1 and IFN-gamma cross-regulate antigen presentation to CD4 T cells by macrophages.
    Delvig AA; Lee JJ; Chrzanowska-Lightowlers ZM; Robinson JH
    J Leukoc Biol; 2002 Jul; 72(1):163-6. PubMed ID: 12101276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).
    Takamura Y; Ikeda H; Kanaseki T; Toyota M; Tokino T; Imai K; Houkin K; Sato N
    Glia; 2004 Mar; 45(4):392-405. PubMed ID: 14966870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide inhibits INFgamma-induced increases in CIITA mRNA abundance and activation of CIITA dependent genes--class II MHC, Ii and H-2M. Class II TransActivator.
    Kielar ML; Sicher SC; Penfield JG; Jeyarajah DR; Lu CY
    Inflammation; 2000 Oct; 24(5):431-45. PubMed ID: 10921507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.
    Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW
    Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation or inhibition of IFN-gamma-induced MHC class II expression by lipopolysaccharides. The roles of TNF-alpha and nitric oxide, and the importance of the sequence of signaling.
    Sicher SC; Chung GW; Vazquez MA; Lu CY
    J Immunol; 1995 Dec; 155(12):5826-34. PubMed ID: 7499872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma-induced MHC class II gene expression is suppressed in endothelial cells by dextran sulfate.
    Lian RH; Kotwal GJ; Wellhausen SR; Hunt LA; Justus DE
    J Immunol; 1996 Jul; 157(2):864-73. PubMed ID: 8752940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class II transactivator suppresses transcription of thyroid-specific genes.
    Mori-Aoki A; Pietrarelli M; Nakazato M; Caturegli P; Kohn LD; Suzuki K
    Biochem Biophys Res Commun; 2000 Nov; 278(1):58-62. PubMed ID: 11071855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
    Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
    Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
    Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP
    J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.